Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9
Original Research
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,289 | Dovepress* | 3,948+ | 171 | 4,119 | |
PubMed Central* | 341 | 137 | 478 | ||
Totals | 4,289 | 308 | 4,597 | ||
*Since 11 October 2022 |
View citations on PubMed Central and Google Scholar